|
11.
|
|
12 p, 998.2 KB |
Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia : prescription Self Audit
/
Pons Mesquida, M. Àngels (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Oms Arias, Míriam (Institut Català de la Salut. Unitat de Coordinació i Estratègia del Medicament) ;
Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Diogène Fadini, Eduard (Hospital Universitari Vall d'Hebron)
In 2008, in the context of a complete computerisation of medical records, the Institut Català de la Salut (ICS, Catalan Health Institute) implemented a system in its electronic clinical workstation (ECW) to assist decision-making at the prescription level. [...]
2022 -  10.1186/s12911-022-01809-6
BMC Medical Informatics and Decision Making, Vol. 22 (march 2022)
|
|
|
12.
|
|
16 p, 3.9 MB |
Analysis of the Long-Lived Responses Induced by Immunostimulants and Their Effects on a Viral Infection in Zebrafish (Danio rerio)
/
Álvarez-Rodríguez, Margarita (Institute of Marine Research (IIM), National Research Council (CSIC)) ;
Pereiro, Patricia (Institute of Marine Research (IIM), National Research Council (CSIC)) ;
Reyes-López, Felipe E. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Tort Bardolet, Lluís (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Figueras, Antonio (Institute of Marine Research (IIM), National Research Council (CSIC)) ;
Novoa, Beatriz (Institute of Marine Research (IIM), National Research Council (CSIC))
In recent years, the innate immune response has gained importance since evidence indicates that after an adequate priming protocol, it is possible to obtain some prolonged and enhanced immune responses. [...]
2018 - 10.3389/fimmu.2018.01575
Frontiers in immunology, Vol. 9 (july 2018)
|
|
|
13.
|
|
|
14.
|
|
7 p, 364.6 KB |
The "Square Box" : Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
/
Cappello, Bernadette (Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland) ;
Moja, Lorenzo (Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland) ;
Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Magrini, Nicola (Italian Medicines Agency, Rome)
Every two years, the World Health Organization (WHO) updates its Model List of Essential Medicines, intended as a guide for countries to adopt or adapt in accordance with local priorities and treatment guidelines, for the development of national essential medicines lists. [...]
2020 - 10.3389/fphar.2020.578000
Frontiers in Pharmacology, Vol. 11 (september 2020)
|
|
|
15.
|
|
10 p, 369.7 KB |
Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda : A Pilot Study to Assess Guideline Concordance
/
Nambasa, Victoria (Directorate of Product Safety, Uganda) ;
Ndagije, Helen B. (Directorate of Product Safety, Uganda) ;
Serwanga, Allan (Directorate of Product Safety, Uganda) ;
Manirakiza, Leonard (Directorate of Product Safety, Uganda) ;
Atuhaire, Joanitah (Directorate of Product Safety, Uganda) ;
Nakitto, Diana (Directorate of Product Safety, Uganda) ;
Kiguba, Ronald (Makerere University College of Health Sciences, Uganda) ;
Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Background : In Uganda, national tuberculosis (TB) treatment guidelines were revised to include the newer generation fluoroquinolones among the second-line treatment options for multidrug-resistant TB. [...]
2020 - 10.3390/antibiotics9080439
Antibiotics, Vol. 9 (july 2020)
|
|
|
16.
|
|
14 p, 263.0 KB |
Patterns of Antibiotic Prescription in Colombia : Are There Differences between Capital Cities and Municipalities?
/
Machado-Alba, Jorge Enrique (Universidad Tecnológica de Pereira (Colòmbia). Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia) ;
Valladales-Restrepo, Luis Fernando (Fundación Universitaria Autónoma de las Américas (Pereira, Colòmbia). Grupo de Investigación Biomedicina) ;
Gaviria-Mendoza, Andrés (Fundación Universitaria Autónoma de las Américas (Pereira, Colòmbia). Grupo de Investigación Biomedicina) ;
Machado-Duque, Manuel Enrique (Fundación Universitaria Autónoma de las Américas (Pereira, Colòmbia). Grupo de Investigación Biomedicina) ;
Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
The use of antibiotics is the most important modifiable risk factor for the development of microorganism resistance. A cross-sectional study of outpatients receiving antibiotic prescriptions registered in a population database in Colombia was conducted. [...]
2020 - 10.3390/antibiotics9070389
Antibiotics, Vol. 9 (july 2020)
|
|
|
17.
|
|
22 p, 3.2 MB |
RNA-Seq analysis of European sea bass (Dicentrarchus labrax L.) infected with nodavirus reveals powerful modulation of the stress response
/
Lama, Raquel (Instituto de Investigaciones Marinas (Vigo, Espanya)) ;
Pereiro, Patricia (Instituto de Investigaciones Marinas (Vigo, Espanya)) ;
Valenzuela-Muñoz, Valentina (Centro Interdisciplinario para la Investigación Acuícola (Xile)) ;
Gallardo-Escárate, Cristian (Centro Interdisciplinario para la Investigación Acuícola (Xile)) ;
Tort Bardolet, Lluís (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Figueras, Antonio (Instituto de Investigaciones Marinas (Vigo, Espanya)) ;
Novoa, Beatriz (Instituto de Investigaciones Marinas (Vigo, Espanya))
Nodavirus, or nervous necrosis virus (NNV), is the causative agent of viral encephalopathy and retinopathy (VER), a severe disease affecting numerous fish species worldwide. European sea bass, a cultured species of great economic importance, is highly susceptible to the disease. [...]
2020 - 10.1186/s13567-020-00784-y
Veterinary research, Vol. 51 (2020) , art. 64
|
|
|
18.
|
|
14 p, 1.2 MB |
Safer prescription of drugs : impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia
/
Pons-Mesquida, M. Àngels (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Oms-Arias, Míriam (Institut Català de la Salut. Unitat de Coordinació i Estratègia del Medicament) ;
Diogène Fadini, Eduard (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
In 2008, the Institut Català de la Salut (ICS, Catalan Health Institute) implemented a prescription decision support system in its electronic clinical workstation (ECW), which automatically generates online alerts for general practitioners when a possible medication-related problem (MRP) is detected. [...]
2021 - 10.1186/s12911-021-01710-8
BMC Medical Informatics and Decision Making, Vol. 21 (december 2021)
|
|
|
19.
|
|
6 p, 113.2 KB |
Farmacologia Aplicada [42358]
/
Antonijoan Arbós, Rosa Ma ;
Agustí Escasany, M. Antònia ;
Alberola, Jordi (Alberola i Domingo) ;
Badía, A. (Albert) ;
Castel Llobet, Josep Maria ;
Diogène Fadini, Eduard ;
Figueras, Albert 1961- ;
Laporte Rosselló, Joan-Ramón ;
Marco Valle, Alberto ;
Mora Pérez, Fernando de ;
Torrent Farnell, Josep ;
Vidal Guitart, Xavier ;
Mora Igual, Francisco Javier ;
Gich, Ignasi ;
Morros, Rosa ;
Universitat Autònoma de Barcelona.
Facultat de Medicina
Aplicar els coneixements farmacològics bàsics a l'optimització del desenvolupament (R + D) de fàrmacs i la seva utilització clínica, i ampliar coneixements que facilitin la comprensió de la seva utilització clínica.
Apply basic pharmacological knowledge to drug development optimization (R+D) and clinical use, and expand knowledge to help understand their clinical use.
Aplicar los conocimientos farmacológicos básicos a la optimización del desarrollo (I + D) de fármacos y su utilización clínica, y ampliar conocimientos que faciliten la comprensión de su utilización clínica.
2021-22
Màster Universitari en Farmacologia [1105]
3 documentos
|
|
|
20.
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
